UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Sandimmun50mgmlkoncentrat-SE-PLC-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100003469-00010263, http://ema.europa.eu/fhir/eurdId
/745
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Concentrate for solution for infusion
indication:
Transplantationsindikationer Organtransplantation För prevention av transplantatavstötning efter organtransplantation. Behandling av cellmedierad transplantatavstötning hos patienter som tidigare fått annan immunsuppressiv behandling. Benmärgstransplantation För prevention av transplantatavstötning efter allogen benmärgs- och stamcellstransplantation. Profylax eller behandling av graft-versus-host disease (GVHD).
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: ciclosporin
name
productName: Sandimmun 50 mg/ml koncentrat till infusionsvätska, lösning
part
part: Sandimmun
type: Invented name part
part
part: 50 mg/ml
type: Strength part
part
part: koncentrat till infusionsvätska, lösning
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish